Status: Recruiting
Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication
The goal of this clinical trial is to compare eradication rates of Helicobacter pylori in patients aged 18-70 years with first infection. The main questions it aims to answer are: * Main indicators: the eradication rate of Helicobacter pylori for eradication. * Secondary indicators: symptomatic relief rate at 2 weeks after treatment and 4 weeks after the end of treatment; compliance and adverse reactions during treatment.
Participants needed: 1,404
Trial details
Phase: Phase 4Age: 18-70Biological sex: AllType: InterventionalSponsor: Xijing Hospital of Digestive DiseasesUpdated: Aug 13, 2024Locations: 1
Eligibility criteria
Age 18-70 years, regardless of sex; chronic gastritis, peptic ulcer or dyspeptic...
Have contraindications to the study drug or are allergic to the study drug; have...